Biosig Technologies Inc (BSGM)

$1.36

-0.13

(-8.72%)

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Biosig Technologies Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 135.0K → 1.0K (in $), with an average decrease of 88.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -11.09M → -4.56M (in $), with an average increase of 142.8% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 31.5% return, outperforming this stock by 119.1%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 71.6% return, outperforming this stock by 168.4%

Performance

  • $1.17
    $1.57
    $1.36
    downward going graph

    13.96%

    Downside

    Day's Volatility :25.47%

    Upside

    13.38%

    downward going graph
  • $0.26
    $16.50
    $1.36
    downward going graph

    80.74%

    Downside

    52 Weeks Volatility :98.41%

    Upside

    91.76%

    downward going graph

Returns

PeriodBiosig Technologies IncIndex (Russel 2000)
3 Months
-54.05%
0.0%
6 Months
-75.97%
0.0%
1 Year
-87.64%
-0.7%
3 Years
-96.77%
-21.3%

Highlights

Market Capitalization
13.4M
Book Value
- $0.15
Earnings Per Share (EPS)
-4.7
PEG Ratio
0.0
Wall Street Target Price
55.0
Profit Margin
0.0%
Operating Margin TTM
-405100.0%
Return On Assets TTM
-449.0%
Return On Equity TTM
-5977.35%
Revenue TTM
141.0K
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
-99.3%
Gross Profit TTM
242.0K
EBITDA
-29.0M
Diluted Eps TTM
-4.7
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.7
EPS Estimate Next Year
-1.5
EPS Estimate Current Quarter
-0.1
EPS Estimate Next Quarter
-0.1

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Biosig Technologies Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 3944.12%

Current $1.36
Target $55.00

Technicals Summary

Sell

Neutral

Buy

Biosig Technologies Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biosig Technologies Inc
Biosig Technologies Inc
157.09%
-75.97%
-87.64%
-96.77%
-97.95%
Stryker Corporation
Stryker Corporation
-3.82%
29.52%
17.24%
35.58%
76.84%
Boston Scientific Corp.
Boston Scientific Corp.
1.81%
35.87%
31.49%
71.59%
80.03%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-3.3%
26.67%
7.02%
4.67%
43.13%
Abbott Laboratories
Abbott Laboratories
-8.2%
18.37%
4.95%
-10.2%
40.79%
Medtronic Plc
Medtronic Plc
-5.05%
11.68%
-0.72%
-35.33%
-7.76%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biosig Technologies Inc
Biosig Technologies Inc
NA
NA
0.0
-3.7
-59.77
-4.49
NA
-0.15
Stryker Corporation
Stryker Corporation
42.0
42.0
2.96
11.85
0.18
0.07
0.01
48.92
Boston Scientific Corp.
Boston Scientific Corp.
64.16
64.16
1.81
2.25
0.09
0.04
NA
13.16
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
39.74
39.74
5.26
2.76
0.22
0.12
NA
11.06
Abbott Laboratories
Abbott Laboratories
34.1
34.1
6.1
4.59
0.15
0.06
0.02
22.26
Medtronic Plc
Medtronic Plc
26.14
26.14
1.56
5.2
0.08
0.04
0.03
38.95
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biosig Technologies Inc
Biosig Technologies Inc
Buy
$13.4M
-97.95%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$132.1B
76.84%
42.0
15.44%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$100.9B
80.03%
64.16
11.18%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$55.0B
43.13%
39.74
23.36%
Abbott Laboratories
Abbott Laboratories
Buy
$192.9B
40.79%
34.1
14.27%
Medtronic Plc
Medtronic Plc
Buy
$109.3B
-7.76%
26.14
13.0%

Institutional Holdings

  • Vanguard Group Inc

    2.55%
  • BlackRock Inc

    0.64%
  • Geode Capital Management, LLC

    0.61%
  • State Street Corporation

    0.19%
  • PFG Investments, LLC

    0.17%
  • Commonwealth Equity Services Inc

    0.13%

Company Information

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.

Organization
Biosig Technologies Inc
Employees
47
CEO
Mr. Frederick D. Hrkac
Industry
Health Technology

FAQs